✉ Email this page to a colleague
« Back to Dashboard
Volasertib is an investigational drug.
There have been 25 clinical trials for Volasertib. The most recent clinical trial was a Phase 3 trial, which was initiated on January 29th 2013.
The most common disease conditions in clinical trials are Leukemia, Leukemia, Myeloid, Acute, and Leukemia, Myeloid. The leading clinical trial sponsors are Boehringer Ingelheim, National Comprehensive Cancer Network, and Anne Beaven, MD.
Recent Clinical Trials for Volasertib
|A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia||University of Alberta||Phase 1|
|A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy Failed||Boehringer Ingelheim||Phase 1|
|Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL||Boehringer Ingelheim||Phase 1|